SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
¶
– Release Delayed ·As Of Filer Filing For·On·As Docs:Size 10/19/16 Monsanto Co/New 10-K¶ 8/31/16 168:23M |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.68M 168: COVER ¶ Comment-Response or Cover Letter to the SEC HTML 46K 2: EX-10.13 Material Contract HTML 85K 3: EX-10.15.15 Material Contract HTML 87K 4: EX-10.15.16 Material Contract HTML 75K 6: EX-21 Subsidiaries List HTML 47K 7: EX-23 Consent of Experts or Counsel HTML 46K 5: EX-12 Statement re: Computation of Ratios HTML 79K 8: EX-31.1 Certification -- §302 - SOA'02 HTML 54K 9: EX-31.2 Certification -- §302 - SOA'02 HTML 54K 10: EX-32 Certification -- §906 - SOA'02 HTML 48K 17: R1 Document and Entity Information HTML 73K 18: R2 Statements of Consolidated Operations HTML 158K 19: R3 Statements of Consolidated Comprehensive Income HTML 94K 20: R4 Statements of Consolidated Comprehensive Income HTML 62K (Parenthetical) 21: R5 Statements of Consolidated Financial Position HTML 184K 22: R6 Statements of Consolidated Financial Position HTML 73K (Parenthetical) 23: R7 Statements of Consolidated Cash Flows HTML 166K 24: R8 Statements of Consolidated Shareholders Equity HTML 110K 25: R9 Statements of Consolidated Shareholders Equity HTML 47K (Parenthetical) 26: R10 Background and Basis of Presentation HTML 54K 27: R11 Significant Accounting Policies HTML 91K 28: R12 New Accounting Standards HTML 66K 29: R13 Business Combinations HTML 56K 30: R14 Restructuring HTML 124K 31: R15 Receivables HTML 93K 32: R16 Customer Financing Programs HTML 78K 33: R17 Variable Interest Entities HTML 62K 34: R18 Inventory HTML 69K 35: R19 Property, Plant and Equipment HTML 62K 36: R20 Goodwill and Other Intangible Assets HTML 107K 37: R21 Income Taxes HTML 137K 38: R22 Debt and Other Credit Arrangements HTML 103K 39: R23 Fair Value Measurements HTML 157K 40: R24 Financial Instruments HTML 388K 41: R25 Postretirement Benefits - Pensions HTML 559K 42: R26 Postretirement Benefits - Health Care and Other HTML 124K Postemployment Benefits 43: R27 Employee Savings Plans HTML 50K 44: R28 Stock-Based Compensation Plans HTML 160K 45: R29 Capital Stock HTML 57K 46: R30 Accumulated Other Comprehensive Loss HTML 117K 47: R31 Earnings Per Share HTML 57K 48: R32 Supplemental Cash Flow Information HTML 62K 49: R33 Commitments and Contingencies HTML 145K 50: R34 Segment and Geographic Data HTML 175K 51: R35 Quarterly Data (Unaudited) HTML 144K 52: R36 Subsequent Event HTML 63K 53: R37 Significant Accounting Policies (Policies) HTML 143K 54: R38 Restructuring Restructuring (Tables) HTML 123K 55: R39 Receivables (Tables) HTML 91K 56: R40 Customer Financing Programs (Tables) HTML 73K 57: R41 Variable Interest Entities (Tables) HTML 52K 58: R42 Inventory (Tables) HTML 70K 59: R43 Property, Plant and Equipment (Tables) HTML 58K 60: R44 Goodwill and Other Intangible Assets (Tables) HTML 104K 61: R45 Income Taxes (Tables) HTML 138K 62: R46 Debt and Other Credit Arrangements (Tables) HTML 100K 63: R47 Fair Value Measurements (Tables) HTML 134K 64: R48 Financial Instruments (Tables) HTML 368K 65: R49 Postretirement Benefits - Pensions (Tables) HTML 565K 66: R50 Postretirement Benefits - Health Care and Other HTML 133K Postemployment Benefits (Tables) 67: R51 Stock-Based Compensation Plans (Tables) HTML 148K 68: R52 Accumulated Other Comprehensive Loss (Tables) HTML 115K 69: R53 Earnings Per Share (Tables) HTML 55K 70: R54 Supplemental Cash Flow (Tables) HTML 52K 71: R55 Commitments and Contingencies (Tables) HTML 124K 72: R56 Segment and Geographic Data (Tables) HTML 174K 73: R57 Quarterly Data (Unaudited) (Tables) HTML 142K 74: R58 BACKGROUND AND BASIS OF PRESENTATION Narrative HTML 67K (Details) 75: R59 Significant Accounting Policies (Narrative) HTML 49K (Details) 76: R60 Significant Accounting Policies (Other Intangible HTML 60K Assets - Narrative) (Details) 77: R61 Significant Accounting Policies (Property, Plant HTML 56K and Equipment - Narrative) (Details) 78: R62 Business Combinations (Narrative) (Details) HTML 57K 79: R63 RESTRUCTURING - Schedule of restructuring charges HTML 81K recored in the statement of consolidated operations (Details) 80: R64 RESTRUCTURING RESTRUCTURING - Pretax restructuring HTML 92K charges related to 2015 restructuring (Details) 81: R65 RESTRUCTURING - Restructuring Charges by Activity HTML 85K (Details) 82: R66 RESTRUCTURING - Narrative (Details) HTML 80K 83: R67 Receivables (Details) HTML 71K 84: R68 Receivables (Trade Receivables by Customer HTML 72K Concentration) (Details) 85: R69 Customer Financing Programs (Details) HTML 73K 86: R70 VARIABLE INTEREST ENTITIES Narrative (Details) HTML 70K 87: R71 VARIABLE INTEREST ENTITIES - Equity Method and HTML 53K Cost Method Investments (Details) 88: R72 Inventory (Details) HTML 76K 89: R73 Inventory INVENTORY - Impairment (Details) HTML 61K 90: R74 Property, Plant and Equipment (Details) HTML 83K 91: R75 GOODWILL AND OTHER INTANGIBLE ASSETS Schedule of HTML 63K net carrying amount of goodwill (Details) 92: R76 GOODWILL AND OTHER INTANGIBLE ASSETS Information HTML 78K of other intangible assets (Details) 93: R77 GOODWILL AND OTHER INTANGIBLE ASSETS Schedule of HTML 56K estimated amortization expense (Details) 94: R78 Income Taxes (Components of income from continuing HTML 52K operations) (Details) 95: R79 Income Taxes (Components of income tax provision) HTML 76K (Details) 96: R80 Income Taxes (Income Tax Reconciliation) (Details) HTML 71K 97: R81 Income Taxes (Components of deferred tax assets HTML 82K and liabilities) (Details) 98: R82 Income Taxes (Narrative) (Details) HTML 65K 99: R83 Income Taxes (Reconciliation of unrecognized tax HTML 61K benefits) (Details) 100: R84 Income Taxes (Years subject to examination) HTML 59K (Details) 101: R85 Debt and Other Credit Arrangements (Short-term HTML 57K Debt) (Details) 102: R86 Debt and Other Credit Arrangements (Long-term HTML 134K Debt) (Details) 103: R87 Debt and Other Credit Arrangements (Narrative) HTML 125K (Details) 104: R88 Debt and Other Credit Arrangements (Interest HTML 52K expense) (Details) 105: R89 Fair Value Measurements (Fair Value Hierarchy HTML 98K Levels) (Details) 106: R90 Fair Value Measurements (Summary of the Change in HTML 70K Level 3 Liability) (Details) 107: R91 Fair Value Measurements (Narrative) (Details) HTML 98K 108: R92 FINANCIAL INSTRUMENTS Narrative (Details) HTML 66K 109: R93 FINANCIAL INSTRUMENTS Notional Amounts of HTML 60K Derivative Instruments Outstanding (Details) 110: R94 FINANCIAL INSTRUMENTS Fair Value of Derivatives HTML 199K Outstanding (Details) 111: R95 FINANCIAL INSTRUMENTS Gain (Loss) from Derivatives HTML 96K (Details) 112: R96 Postretirement Benefits - Pensions (Narrative) HTML 82K (Details) 113: R97 Postretirement Benefits - Pensions (Components of HTML 82K Net Periodic Benefit Cost) (Details) 114: R98 Postretirement Benefits - Pensions (Changes HTML 71K Recognized in OCI Pension) (Details) 115: R99 Postretirement Benefits - Pensions (Assumptions HTML 58K Used to Determine Pension Costs) (Details) 116: R100 Postretirement Benefits - Pensions (Schedule of HTML 132K Funded Status) (Details) 117: R101 Postretirement Benefits - Pensions (Assumptions HTML 54K Used to Determine Pension Benefit Obligation) (Details) 118: R102 Postretirement Benefits - Pensions (Projected HTML 57K Benefit Obligations in Excess of Plan Assets) (Details) 119: R103 Postretirement Benefits - Pensions (Accumulated HTML 62K Benefit Obligations in Excess of Plan Assets) (Details) 120: R104 Postretirement Benefits - Pensions (Net Amount HTML 66K Recognized) (Details) 121: R105 Postretirement Benefits - Pensions (Pre-Tax HTML 62K Components Recognized in AOCI Pension) (Details) 122: R106 Postretirement Benefits - Pensions (Pension Plan HTML 74K Asset Allocation United States) (Details) 123: R107 Postretirement Benefits - Pensions (Pension Plan HTML 66K Asset Allocation Foreign) (Details) 124: R108 Postretirement Benefits - Pensions (United States HTML 192K Pension Plan Asset Fair Value) (Details) 125: R109 Postretirement Benefits - Pension (United States HTML 76K Pension Plan Asset Level 3 Rollforward) (Details) 126: R110 Postretirement Benefits - Pensions (Investments at HTML 63K Fair Value to Plan Assets Reconciliation) (Details) 127: R111 Postretirement Benefits - Pensions (Foreign HTML 107K Pension Plan Asset Fair Value) (Details) 128: R112 Postretirement Benefits - Pension (Foreign Pension HTML 61K Plan Asset Level 3 Rollforward) (Details) 129: R113 Postretirement Benefits - Pension Summary of HTML 70K Unfunded Commitments and Redemption Features Measured Using NAV (Details) 130: R114 Postretirement Benefits - Pension (Expected Cash HTML 69K Flows Pension) (Details) 131: R115 Postretirement Benefits - Health Care and Other HTML 67K Postemployment Benefits (Narrative) (Details) 132: R116 Postretirement Benefits - Health Care and Other HTML 62K Postemployment Benefits (Net Periodic Cost Postretirement) (Details) 133: R117 Postretirement Benefits - Health Care and Other HTML 69K Postemployment Benefits (Changes Recognized in OCI Postretirement) (Details) 134: R118 Postretirement Benefits - Health Care and Other HTML 55K Postemployment Benefits (Assumptions Used to Determine Postretirement Costs) (Details) 135: R119 Postretirement Benefits - Health Care and Other HTML 56K Postemployment Benefits (One Percent Effect on Postretirement Costs and Benefit Obligation) (Details) 136: R120 Postretirement Benefits - Health Care and Other HTML 71K Postemployment Benefits (Benefit Obligations Postretirement) (Details) 137: R121 Postretirement Benefits - Health Care and Other HTML 56K Postemployment Benefits (Assumptions Used to Determine Postretirement Benefit Obligation) (Details) 138: R122 Postretirement Benefits - Health Care and Other HTML 58K Postemployment Benefits (Postretirement Amounts Recognized in Statements of Consolidated Financial Position) (Details) 139: R123 Postretirement Benefits - Health Care and Other HTML 55K Postemployment Benefits (Pre-Tax Components Recognized in AOCI Postretirement) (Details) 140: R124 Postretirement Benefits - Health Care and Other HTML 68K Postemployment Benefits (Expected Cash Flows Postretirement) (Details) 141: R125 Employee Savings Plans (Details) HTML 63K 142: R126 Stock-Based Compensation Plans (Narrative) HTML 129K (Details) 143: R127 Stock-Based Compensation Plans (Components of HTML 76K Stock Based Compensation) (Details) 144: R128 Stock-Based Compensation Plans (Rollforward of HTML 67K Stock Options) (Details) 145: R129 Stock-Based Compensation Plans (Restricted Stock) HTML 100K (Details) 146: R130 Stock-Based Compensation Plans (Assumptions Used HTML 64K to Value Stock Options) (Details) 147: R131 Capital Stock (Common Stock and Preferred Stock) HTML 58K (Details) 148: R132 Capital Stock (Treasury Stock) (Details) HTML 79K 149: R133 Accumulated Other Comprehensive Loss (Details) HTML 110K 150: R134 Earnings Per Share (Details) HTML 56K 151: R135 Supplemental Cash Flow Information Supplemental HTML 49K Cash Flow Information (Details) 152: R136 SUPPLEMENTAL CASH FLOW INFORMATION Narrative HTML 51K (Details) 153: R137 Commitments and Contingencies (Contractual HTML 107K Obligations) (Details) 154: R138 Commitments and Contingencies (Leases and HTML 48K Guarantees Narrative) (Details) 155: R139 Commitments and Contingencies (Environmental HTML 52K Liabilities Narrative) (Details) 156: R140 Commitments and Contingencies (Discounted and HTML 68K Undiscounted Environmental and Litigation Liabilities) (Details) 157: R141 Commitments and Contingencies (Environmental and HTML 54K Litigation Liabilities) (Details) 158: R142 Commitments and Contingencies (Litigation HTML 67K Narrative) (Details) 159: R143 Commitments and Contingencies Off-Balance Sheet HTML 48K Arrangements (Details) 160: R144 Segment and Geographic Data (Operating Segment HTML 132K Information) (Details) 161: R145 Segment and Geographic Data (The reconciliation of HTML 60K EBIT to Net Income) (Details) 162: R146 Segment and Geographic Data (Net Sales And Long HTML 87K Lived Assets by World Area) (Details) 163: R147 Quarterly Data (Unaudited) (Details) HTML 157K 164: R148 Subsequent Event (Details) HTML 72K 166: XML IDEA XML File -- Filing Summary XML 327K 165: EXCEL IDEA Workbook of Financial Reports XLSX 229K 11: EX-101.INS XBRL Instance -- mon-20160831 XML 8.78M 13: EX-101.CAL XBRL Calculations -- mon-20160831_cal XML 460K 14: EX-101.DEF XBRL Definitions -- mon-20160831_def XML 1.76M 15: EX-101.LAB XBRL Labels -- mon-20160831_lab XML 3.56M 16: EX-101.PRE XBRL Presentations -- mon-20160831_pre XML 2.46M 12: EX-101.SCH XBRL Schema -- mon-20160831 XSD 425K 167: ZIP XBRL Zipped Folder -- 0001110783-16-000532-xbrl Zip 636K
Exhibit |
1. | I have reviewed this report on Form 10-K of Monsanto Company; |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed
in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The
registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date:
October 19, 2016 | ||
Senior
Vice President and Chief Financial Officer | ||
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 10/19/16 | 4, DEFA14A, PREM14A | ||
For Period end: | 8/31/16 | 5, 8-K | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/23/17 SEC UPLOAD¶ 10/16/17 1:35K Monsanto Co./New 2/07/17 SEC UPLOAD¶ 10/16/17 1:135K Monsanto Co./New |